These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts. Shinoda M, Hoffer BJ, Olson L. J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240 [Abstract] [Full Text] [Related]
13. [Protective effect of exogenous glial cell line derived neurotrophic factor on neurons after sciatic nerve injury in rats]. Chen ZY, Cao L, Lu CL, He C, Bao X. Sheng Li Xue Bao; 2000 Aug 15; 52(4):295-300. PubMed ID: 11951110 [Abstract] [Full Text] [Related]
16. Interactions of neurotrophic factors GDNF and NT-3, but not BDNF, with the immune system following fetal spinal cord transplantation. Shinoda M, Hoffer BJ, Olson L. Brain Res; 1996 May 25; 722(1-2):153-67. PubMed ID: 8813361 [Abstract] [Full Text] [Related]
17. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Törnqvist N, Björklund L, Almqvist P, Wahlberg L, Strömberg I. Exp Neurol; 2000 Jul 25; 164(1):130-8. PubMed ID: 10877923 [Abstract] [Full Text] [Related]